![James DeTore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James DeTore
Director of Finance/CFO at
CG ONCOLOGY, INC.
Profile
James M.
DeTore is currently Chief Financial Officer at CG Oncology, Inc. since 2026.
Former positions include Chief Financial Officer at Neurogastrx, Inc. from 2021 to 2025; Chief Financial Officer & Treasurer at Proteostasis Therapeutics, Inc. from 2016 to 2017; Chief Financial Officer & Treasurer at Genetix Biotherapeutics, Inc. from 2014 to 2016; Vice President-Finance & Administration at Ironwood Pharmaceuticals, Inc. from 2012 to 2014; Controller at Microbia, Inc. from 2003 to 2006; Principal at Genzyme Corp.; and Principal at Data General Corp.
Education includes undergraduate and MBAistration degrees from Northeastern University.
James DeTore active positions
| Companies | Position | Start |
|---|---|---|
| CG ONCOLOGY, INC. | Director of Finance/CFO | 17/11/2025 |
Former positions of James DeTore
| Companies | Position | End |
|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Director of Finance/CFO | 01/06/2025 |
| PROTEOSTASIS THERAPEUTICS, INC. | Director of Finance/CFO | 10/02/2017 |
| GENETIX BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2016 |
| IRONWOOD PHARMACEUTICALS, INC. | Director of Finance/CFO | 17/06/2011 |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Comptroller/Controller/Auditor | 01/01/2006 |
Training of James DeTore
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Data General Corp.
 Data General Corp. Computer PeripheralsElectronic Technology Designs and makes open computer systems including servers and mass storage products | Electronic Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
- Stock Market
- Insiders
- James DeTore
Choose MarketScreener 
